Evidence map›Paper›PMID 18306988›Full record

ArticleJournal of gastroenterology2008

Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.

Yayoi Ozaki, Kazuhiro Oguchi, Hideaki Hamano, Norikazu Arakura, Takashi Muraki, Kendo Kiyosawa, Mitsuhiro Momose, Masumi Kadoya, Kazunobu Miyata, Takao Aizawa and 1 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study.European journal of nuclear medicine and molecular imaging · 2014
    Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Multiparameter diagnostic model based onQuantitative imaging in medicine and surgery · 2023
    Article
  10. Review
  11. Radiomics model of dual-time 2-[European radiology · 2021
    Article
  12. Article
  13. Review
  14. Diagnostic imaging guide for autoimmune pancreatitis.Japanese journal of radiology · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. [Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features inSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Article
  19. Diffuse Pancreatic Cancer Mimicking Autoimmune Pancreatitis.Internal medicine (Tokyo, Japan) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yayoi OzakiDepartment of Medicine, Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
Kazuhiro Oguchi
Hideaki Hamano
Norikazu Arakura
Takashi Muraki
Kendo Kiyosawa
Mitsuhiro Momose
Masumi Kadoya
Kazunobu Miyata
Takao Aizawa
Shigeyuki Kawa
Shinshu University · JPAizawa Hospital · JPShinshu University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) has been widely used for the diagnosis of pancreatic cancer. Because autoimmune pancreatitis is easily misdiagnosed as pancreatic cancer and can be tested for by FDG-PET analysis based on the presence of suspected pancreatic cancer, we attempted to clarify the differences in FDG-PET findings between the two conditions.

methodsWe compared FDG-PET findings between 15 patients with autoimmune pancreatitis and 26 patients with pancreatic cancer. The findings were evaluated visually or semiquantitatively using the maximum standardized uptake value and the accumulation pattern of FDG.

resultsFDG uptake was found in all 15 patients with autoimmune pancreatitis, whereas it was found in 19 of 26 patients (73.1%) with pancreatic cancer. An accumulation pattern characterized by nodular shapes was significantly more frequent in pancreatic cancer, whereas a longitudinal shape indicated autoimmune pancreatitis. Heterogeneous accumulation was found in almost all cases of autoimmune pancreatitis, whereas homogeneous accumulation was found in pancreatic cancer. Significantly more cases of pancreatic cancer showed solitary localization, whereas multiple localization in the pancreas favored the presence of autoimmune pancreatitis. FDG uptake by the hilar lymph node was significantly more frequent in autoimmune pancreatitis than in pancreatic cancer, and uptake by the lachrymal gland, salivary gland, biliary duct, retroperitoneal space, and prostate were seen only in autoimmune pancreatitis.

conclusionsFDG-PET is a useful tool for differentiating autoimmune pancreatitis from suspected pancreatic cancer, if the accumulation pattern and extrapancreatic involvement are considered. IgG4 measurement and other current image tests can further confirm the diagnosis.

Indexed as

Positron-Emission TomographyAdenocarcinomaAdultAgedAutoimmune DiseasesDiagnosis, DifferentialFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedPancreatic NeoplasmsPancreatitisRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID18306988
OpenAlexW2038797446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.